EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C24H24N6O2 |
| Net Charge | 0 |
| Average Mass | 428.496 |
| Monoisotopic Mass | 428.19607 |
| SMILES | COc1cc(Nc2nccc(Nc3cnc4ccccc4c3)n2)ccc1N1CCOCC1 |
| InChI | InChI=1S/C24H24N6O2/c1-31-22-15-18(6-7-21(22)30-10-12-32-13-11-30)28-24-25-9-8-23(29-24)27-19-14-17-4-2-3-5-20(17)26-16-19/h2-9,14-16H,10-13H2,1H3,(H2,25,27,28,29) |
| InChIKey | LNEPMZDEABTAPY-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | insulin-like growth factor receptor 1 antagonist An antagonist at the insulin-like growth factor receptor 1. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) has role insulin-like growth factor receptor 1 antagonist (CHEBI:75252) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a aminopyrimidine (CHEBI:38338) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a aminoquinoline (CHEBI:36709) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a monomethoxybenzene (CHEBI:25235) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a morpholines (CHEBI:38785) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a secondary amino compound (CHEBI:50995) |
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine (CHEBI:90540) is a tertiary amino compound (CHEBI:50996) |
| IUPAC Name |
|---|
| N2-[3-methoxy-4-(morpholin-4-yl)phenyl]-N4-(quinolin-3-yl)pyrimidine-2,4-diamine |
| Manual Xrefs | Databases |
|---|---|
| 01P | PDBeChem |
| Registry Numbers | Sources |
|---|---|
| Reaxys:21376854 | Reaxys |
| Citations |
|---|